Financial relationships between institutional review board members and industry.
about
Human recombinant activated protein C for severe sepsisApplying research ethics guidelines: the view from a sub-saharan research ethics committee.Incidence of osteosynthesis of members in France.IRB chairs' perspectives on genotype-driven research recruitment.More regulation of industry-supported biomedical research: are we asking the right questions?How are the interests of incapacitated research participants protected through legislation? An Italian study on legal agency for dementia patients."Members of the same club": challenges and decisions faced by US IRBs in identifying and managing conflicts of interest.Institutional review board challenges related to community-based participatory research on human exposure to environmental toxins: a case studyKey personnel and "long distance" settings: determining who must report financial conflict of interest.Conflicts of Interest in GM Bt Crop Efficacy and Durability Studies.Institutional review boards' use and understanding of certificates of confidentiality.Are central institutional review boards the solution? The National Heart, Lung, and Blood Institute Working Group's report on optimizing the IRB process.Conflict of interest in clinical research.A systematic review of the empirical literature evaluating IRBs: what we know and what we still need to learnInstitutional review board community members: who are they, what do they do, and whom do they represent?Ethical issues concerning therapeutic studies in inflammatory bowel disease.Ethics and technology transfer: patients, patents, and public trust.Correlation between financial relationships with commercial interests and research prominence at an oncology meeting.Health for all? Dream on!"Conflict-of-interest" and participation in IRB deliberations: an alternative perspective.Policies and management of conflicts of interest within medical research institutional review boards: results of a national study.UNIVERSITY TRUSTEES AS CHANNELS BETWEEN ACADEME AND INDUSTRY: TOWARD AN UNDERSTANDING OF THE EXECUTIVE SCIENCE NETWORK.Opinions of IRB Members and Chairs Regarding Investigators' Relationships with Industry.U.S. research universities' institutional conflict of interest policies.Institutional review boards: Challenges and opportunities.Towards a balanced approach to identifying conflicts of interest faced by institutional review boards.Ethical considerations in clinical trials: a critique of the ICH-GCP guideline.Meeting the Challenge: The National Cancer Institute's Central Institutional Review Board for Multi-Site Research.Reporting conflicts of interest: clarifying the grey areas.Having Their Cake and Eating It Too: Physician Skepticism of the Open Payments Program.
P2860
Q24242859-86E8C0A2-2625-415E-A134-B401D0B6ACDDQ30431359-CA82FB21-2E2D-49CC-A5B7-E8401B19FDFBQ30491769-898C3F03-1BFA-45E8-9525-D124E95A3547Q30539071-27FE25C1-095C-44FE-AB9F-AEF0BC24436CQ33499060-EB302A35-5F3B-4CE2-BE6B-B5F95FCE77A8Q33618942-51BB5063-61F2-4B96-9542-58CEEABCD2D6Q33987895-02CFC064-037A-4823-AD7B-C3B0E0355E48Q34036253-F4B5BDAB-4F8E-4DB6-A15B-CE6A9040FB94Q34044626-CA504FCF-4163-44B2-A168-30220A48668EQ34047785-191FF99B-2686-4C90-9A63-1FE0A021800CQ34409785-48E11850-F8AF-4B08-BB48-92AE1E32FAEEQ34713422-A689A5E9-B19E-4344-BC7F-A8AD17534110Q35041593-D9D8EF5E-59BE-406E-A857-3756AF04C9CFQ35606493-6DDE932A-6564-49D8-9387-FA271DC94601Q36546855-D564D4DF-528D-4424-AA97-4FF7EF6A0B46Q36757557-C0D2E02D-2E8D-4D86-B88F-A5F8790AA607Q36989294-79B36452-3297-4DBD-8F00-15D6E8785D58Q37004753-819D2521-EA4F-4CBA-9F34-1DB85F9BE70EQ37020458-BC7A0EDB-3AD7-497A-BBA0-0075A6036BFAQ37079908-2B5D050E-2837-4762-A9C9-BEE8D9653C33Q37156907-45360D1B-3F9E-4EB9-A38C-A8CBA3A2E214Q37190796-A4D6B0E4-68F6-4587-8EAE-31C76BF883EBQ37455013-9F7DAFC2-E0EA-4D94-8AA3-96A33D4D4B66Q37597167-771339D9-3578-442E-9264-6FC3814D5B22Q37693384-4068C7C7-5138-49C8-A97F-02D0F6BACF0BQ38599599-80020815-35C5-4A45-8A89-FC82C2487E66Q48351212-15C8AE96-8EEC-483C-A416-66C6855A6B9DQ49559109-90C1A7CE-30E0-4940-ACA2-ED8C52092F01Q53140137-B20A5B76-1E4C-4665-9D15-7D42D04B684BQ53271775-FA4C5F25-9EE8-4211-8667-89E1C704DF1F
P2860
Financial relationships between institutional review board members and industry.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Financial relationships between institutional review board members and industry.
@ast
Financial relationships between institutional review board members and industry.
@en
type
label
Financial relationships between institutional review board members and industry.
@ast
Financial relationships between institutional review board members and industry.
@en
prefLabel
Financial relationships between institutional review board members and industry.
@ast
Financial relationships between institutional review board members and industry.
@en
P2093
P356
P1476
Financial relationships between institutional review board members and industry.
@en
P2093
Brian R Clarridge
Christine Vogeli
Eric G Campbell
Greg Koski
Jessica E Marder
Joel S Weissman
Melissa Abraham
P304
P356
10.1056/NEJMSA061457
P407
P577
2006-11-01T00:00:00Z